Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $42.28 million. The enterprise value is $40.58 million.
Important Dates
The last earnings date was Monday, March 16, 2026, after market close.
| Earnings Date | Mar 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 8.18 million shares outstanding. The number of shares has increased by 69.85% in one year.
| Current Share Class | 8.18M |
| Shares Outstanding | 8.18M |
| Shares Change (YoY) | +69.85% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 2.41% |
| Owned by Institutions (%) | 27.77% |
| Float | 5.59M |
Valuation Ratios
The trailing PE ratio is 2.01.
| PE Ratio | 2.01 |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| Forward PS | 3.24 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 1.24 |
| EV / Sales | 0.34 |
| EV / EBITDA | 0.79 |
| EV / EBIT | 0.82 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.82
| Current Ratio | 0.82 |
| Quick Ratio | 0.65 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.18 |
| Debt / FCF | n/a |
| Interest Coverage | 13.05 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 47.81% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 931.13% |
| Weighted Average Cost of Capital (WACC) | 9.63% |
| Revenue Per Employee | $8.63M |
| Profits Per Employee | $2.33M |
| Employee Count | 14 |
| Asset Turnover | 1.87 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATRA has paid $31,000 in taxes.
| Income Tax | 31,000 |
| Effective Tax Rate | 0.09% |
Stock Price Statistics
The stock price has decreased by -12.96% in the last 52 weeks. The beta is -0.33, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | -12.96% |
| 50-Day Moving Average | 5.08 |
| 200-Day Moving Average | 10.75 |
| Relative Strength Index (RSI) | 48.79 |
| Average Volume (20 Days) | 337,203 |
Short Selling Information
The latest short interest is 313,290, so 3.83% of the outstanding shares have been sold short.
| Short Interest | 313,290 |
| Short Previous Month | 330,524 |
| Short % of Shares Out | 3.83% |
| Short % of Float | 5.60% |
| Short Ratio (days to cover) | 0.81 |
Income Statement
In the last 12 months, ATRA had revenue of $120.77 million and earned $32.69 million in profits. Earnings per share was $2.57.
| Revenue | 120.77M |
| Gross Profit | 74.62M |
| Operating Income | 49.47M |
| Pretax Income | 32.72M |
| Net Income | 32.69M |
| EBITDA | 51.59M |
| EBIT | 49.47M |
| Earnings Per Share (EPS) | $2.57 |
Full Income StatementBalance Sheet
The company has $8.48 million in cash and $10.38 million in debt, with a net cash position of -$1.89 million or -$0.23 per share.
| Cash & Cash Equivalents | 8.48M |
| Total Debt | 10.38M |
| Net Cash | -1.89M |
| Net Cash Per Share | -$0.23 |
| Equity (Book Value) | -38.50M |
| Book Value Per Share | -5.26 |
| Working Capital | -2.71M |
Full Balance SheetCash Flow
| Operating Cash Flow | -50.94M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.12M |
| Net Borrowing | -250,000 |
| Free Cash Flow | -50.94M |
| FCF Per Share | -$6.23 |
Full Cash Flow StatementMargins
Gross margin is 61.79%, with operating and profit margins of 40.96% and 27.07%.
| Gross Margin | 61.79% |
| Operating Margin | 40.96% |
| Pretax Margin | 27.09% |
| Profit Margin | 27.07% |
| EBITDA Margin | 42.71% |
| EBIT Margin | 40.96% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -69.85% |
| Shareholder Yield | -69.85% |
| Earnings Yield | 84.50% |
| FCF Yield | -131.69% |
Analyst Forecast
The average price target for ATRA is $5.00, which is -3.29% lower than the current price. The consensus rating is "Sell".
| Price Target | $5.00 |
| Price Target Difference | -3.29% |
| Analyst Consensus | Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 0.76% |
| EPS Growth Forecast (5Y) | -3.58% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ATRA has an Altman Z-Score of -125.28 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -125.28 |
| Piotroski F-Score | 5 |
